1-{[(4R,7S,10S,13S,16S,19R)-19-Amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}-L-p rolyl-L-lysylglycinamide(CAS: 50-57-7)

Regulatory guidelines for this compound include those under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), as well as specific regulations from the European Union's REACH program. Additionally, the U.S. Food and Drug Administration (FDA) and Environmental Protection Agency (EPA) may have specific requirements depending on the intended use of the compound. Companies must consult the latest regulatory guidelines for compliance and ensure proper labeling, handling, and reporting.

There are several alternatives to this compound in synthesis, including related amino acids and their derivatives. Common substitutes include 1-prolyl-L-lysine and other cyclic peptides. Researchers often explore these alternatives based on specific functional requirements and availability of reagents.

Market trends for this compound are driven by its potential applications in pharmaceuticals, especially in drug discovery and development. Research is focusing on its use as a bioactive compound in treating various diseases. Market trends also reflect increasing interest in cyclic peptides as drug candidates due to their favorable pharmacokinetic properties and target specificity.

Waste containing this compound should be collected in appropriate containers and disposed of according to local regulations. For safe disposal, consider incineration or professional waste disposal services. Ensure proper containment and handling to prevent environmental contamination. Always consult with environmental health and safety experts for guidance on waste management and disposal procedures.